Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Samir, Kochbati"'
Autor:
Sana Bouzid, Houda Hammami-Ghorbel, Amal Chamli, Imen Aounti, Wiem Daly, Samir Kochbati, Samy Fenniche, Anissa Zaouak
Publikováno v:
Therapie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fedabf303cc2014545f389c84f0a455d
https://pubmed.ncbi.nlm.nih.gov/36566160
https://pubmed.ncbi.nlm.nih.gov/36566160
Autor:
Mehdi Somai, Besma Ben Dhaou, Emna Hannech, Fatma Boussema, I. Rachdi, F. Daoud, Hana Zoubeidi, Sarra Hamrouni, Samir Kochbati, Zohra Aydi
Publikováno v:
Open Access Journal of Internal Medicine. 3:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c25c308e31201abce5de1452c886f28c
https://doi.org/10.22259/2638-5279.0301001
https://doi.org/10.22259/2638-5279.0301001
Autor:
Wafa Hamdi, Dhouha Azzouz, Mohamed Mehdi Ghannouchi, Manel Haouel, Samir Kochbati, Kaouthar Saadellaoui, Abdelmajid Ben Hmida, Béchir Zouari, Mohamed Montacer Kchir
Publikováno v:
Oman Medical Journal, Vol 27, Iss 6, Pp 455-460 (2012)
Objectives: The main objective of the study was to examine the self reported health status in patients with ankylosing spondylitis (AS) compared with the general population and the secondary objective (in the AS group) was to study the association be
Externí odkaz:
https://doaj.org/article/8444a16ef5674860be3ae9828aaf7a92
Autor:
Aicha Ladjouze-Rezig, Samir Kochbati, Ouafa Mkinsi, Héla Sahli Srairi, Salima Lefkir-Tafiani, Yasser El Dershaby, Mohamed Mounir El Azhari, Sabrina Ait-Ihaddadene Midjek
Publikováno v:
The Open Rheumatology Journal. 13:72-84
Introduction of innovative biopharmaceuticals has dramatically changed the treatment of chronic inflammatory diseases, but access to these very effective agents may be limited by economic constraints in some regions. The development of biosimilar pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5049f11f7e59a45968adf02b0104be57
https://doi.org/10.2174/1874312901913010072
https://doi.org/10.2174/1874312901913010072
Autor:
Lilia Baili, Imène Rachdi, Fatma Daoud, Zohra Aydi, Basma Ben Dhaou, Samir Kochbati, Fatma Boussema
Publikováno v:
European Journal of Case Reports in Internal Medicine, Vol 1, Iss 1 (2014)
Introduction: Membranous glomerulonephritis is commonly described in systemic lupus erythematosus (SLE) and hypothyroidism. Clinical presentation: We report a case of a 40-year-old woman who presented with a membranous glomerulonephritis associated
Externí odkaz:
https://doaj.org/article/d61b212befaa4e29919b5f58801a6687
Autor:
Lilia Baili, Imène Rachdi, Fatma Daoud, Zohra Aydi, Basma Ben Dhaou, Samir Kochbati, Fatma Boussema
Publikováno v:
European Journal of Case Reports in Internal Medicine, Vol 1, Iss 1 (2014)
Crohn’s disease is a granulomatous inflammatory bowel disease. Its pathologic findings include non-contiguous chronic inflammation and non-caseating granulomas, sometimes with extra-intestinal localizations. Sinonasal manifestations of Crohn’s
Externí odkaz:
https://doaj.org/article/16089ecb644648d382bed6d05bac6bf0
Autor:
L. Abdelmoula, Soufiene Baklouti, Kaouther Maatallah, T. Wafa, W. Hamdi, I. Gharsallah, Samir Kochbati, L. Nacef, Mohamed Montacer Kchir, K. Dhia, Mouna Elleuch, E. Bouahina, A. Laatar, H. Ferjani, Mohamed Younes
Publikováno v:
La Revue de Médecine Interne. 41:A205-A206
Introduction Le developpement des registres nationaux a permis d’obtenir des donnees importantes en ce qui concerne la securite d’emploi des biotherapies au cours des rhumatismes inflammatoires chroniques (RIC). L’objectif de cette etude etait
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9386aa6fcf60149842664c91332bb3c
https://doi.org/10.1016/j.revmed.2020.10.352
https://doi.org/10.1016/j.revmed.2020.10.352
Publikováno v:
Clinical rheumatology. 39(5)
We aimed to assess the safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in a routine clinical practice setting in Tunisian patients with RA who did not respond to conventional treatment with disease-modifying anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23aa0c364abb48f7630c8a83af4b294
https://pubmed.ncbi.nlm.nih.gov/31838637
https://pubmed.ncbi.nlm.nih.gov/31838637
Autor:
L. Abdelmoula, Soufiene Baklouti, Mouna Elleuch, A. Laatar, I. Gharsallah, R. Ben Aissa, Wafa Hamdi, Naceur Bergaoui, Soumaya Boussaid, E. Bouagina, Mohamed Younes, Samir Kochbati
Publikováno v:
Annals of the Rheumatic Diseases. 80:856.2-856
Background:The development of biologics for the treatment of systemic rheumatic diseases increased the risk of infections. The management of this complication deserves particular attention since it remains a major cause of morbidity and mortality.Obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dc81652bf8145d4d70d093f41d3409e
https://doi.org/10.1136/annrheumdis-2021-eular.3000
https://doi.org/10.1136/annrheumdis-2021-eular.3000
Autor:
Soufiene Baklouti, Naceur Bergaoui, Mohamed Younes, Samir Kochbati, Soumaya Boussaid, R. Ben Aissa, E. Bouagina, M. El Euch, Wafa Hamdi, I. Gharsallah, L. Abdelmoula, A. Laatar
Publikováno v:
Annals of the Rheumatic Diseases. 80:1358.1-1358
Background:The screening and treatment of latent tuberculosis infection (LTBI) is required before starting biologic therapy. Tuberculin skin test (TST) and interferon γ gamma release assay (IGRA) are the two commonly used tests.Objectives:The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::258ba88c9c4e5ff7cd749b35fa675527
https://doi.org/10.1136/annrheumdis-2021-eular.2938
https://doi.org/10.1136/annrheumdis-2021-eular.2938